Karen Vousden
Director/Board Member bei BRISTOL-MYERS SQUIBB COMPANY
Vermögen: - $ am 31.03.2024
Profil
Karen H.
Vousden is the founder of Faeth Therapeutics, Inc. She is currently an Independent Director at Bristol Myers Squibb Co., an Associate at National Academy of Sciences, a Council Member at European Molecular Biology Organization, and the President of British Association for Cancer Research.
Previously, she was the Director of The Beatson Institute For Cancer Research from 2002 to 2016.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
14.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Karen Vousden
Unternehmen | Position | Beginn |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Director/Board Member | 01.01.2018 |
European Molecular Biology Organization | Corporate Officer/Principal | - |
British Association for Cancer Research
British Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services The British Association for Cancer Research (BACR) is a professional membership association for all those working and studying in cancer research within and beyond the UK. The BACR is based in Sutton, UK. The BACR aims to promote the advance of research in relation to all aspects of cancer and encourage the exchange of information. The British company provides educational and training opportunities for all those involved in the cancer field, particularly the next generation of cancer research professionals. The private company also organizes scientific conferences and workshops, and offer meeting bursaries and fellowships, to enable their membership to attend cancer-focused events around the world. | President | - |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Faeth Therapeutics, Inc. is a clinical-stage biotechnology company based in TX. The American company focuses on developing precision therapies for metabolic oncology using a machine-learning platform and a metabolic regimen involving the patient's diet. Faeth's lead program combines FTH-001 and FTH-003 with an insulin suppressing regimen to slow tumor growth by shutting down the PI3K/MTOR pathway. The company's scientific founders include Drs. Lew Cantley, Sid Mukherjee, and Karen Vousden. Anand Parikh has been the CEO since incorporation. | Founder | - |
Ehemalige bekannte Positionen von Karen Vousden
Unternehmen | Position | Ende |
---|---|---|
The Beatson Institute For Cancer Research
The Beatson Institute For Cancer Research Miscellaneous Commercial ServicesCommercial Services The Beatson Institute For Cancer Research operates as cancer research institute. The company was founded by George Beatson in 1912 and is headquartered in Bearsden, the United Kingdom. | Director/Board Member | 01.01.2016 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private Unternehmen | 5 |
---|---|
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
European Molecular Biology Organization | |
British Association for Cancer Research
British Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services The British Association for Cancer Research (BACR) is a professional membership association for all those working and studying in cancer research within and beyond the UK. The BACR is based in Sutton, UK. The BACR aims to promote the advance of research in relation to all aspects of cancer and encourage the exchange of information. The British company provides educational and training opportunities for all those involved in the cancer field, particularly the next generation of cancer research professionals. The private company also organizes scientific conferences and workshops, and offer meeting bursaries and fellowships, to enable their membership to attend cancer-focused events around the world. | Commercial Services |
The Beatson Institute For Cancer Research
The Beatson Institute For Cancer Research Miscellaneous Commercial ServicesCommercial Services The Beatson Institute For Cancer Research operates as cancer research institute. The company was founded by George Beatson in 1912 and is headquartered in Bearsden, the United Kingdom. | Commercial Services |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Faeth Therapeutics, Inc. is a clinical-stage biotechnology company based in TX. The American company focuses on developing precision therapies for metabolic oncology using a machine-learning platform and a metabolic regimen involving the patient's diet. Faeth's lead program combines FTH-001 and FTH-003 with an insulin suppressing regimen to slow tumor growth by shutting down the PI3K/MTOR pathway. The company's scientific founders include Drs. Lew Cantley, Sid Mukherjee, and Karen Vousden. Anand Parikh has been the CEO since incorporation. | Health Technology |